The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma

Online veröffentlicht: 10. Juli 2014

Seitenbereich: 219 - 227

Eingereicht: 08. Feb. 2013

Akzeptiert: 21. Aug. 2013

DOI: https://doi.org/10.2478/raon-2013-0067

Schlüsselwörter

fluorodeoxyglucose, positron emission tomography, advanced renal cell carcinoma, tyrosine-kinase inhibitors, response to treatment

© by Carmelo Caldarella

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.